Effect of Denosumab on Peripheral Compartmental Bone Density, Microarchitecture and Estimated Bone S...
Effect of Denosumab on Peripheral Compartmental Bone Density, Microarchitecture and Estimated Bone Strength in De Novo Kidney Transplant Recipients
About this item
Full title
Author / Creator
Publisher
Basel, Switzerland: Karger Publishers
Journal title
Language
English
Formats
Publication information
Publisher
Basel, Switzerland: Karger Publishers
Subjects
More information
Scope and Contents
Contents
Background/Aims: In a randomized controlled clinical trial in kidney transplant recipients (NCT01377467) we have recently shown that RANKL inhibition with denosumab significantly improved areal bone mineral density (aBMD) when given during the first year after transplantation. The effect of denosumab on skeletal microstructure and bone strength in...
Alternative Titles
Full title
Effect of Denosumab on Peripheral Compartmental Bone Density, Microarchitecture and Estimated Bone Strength in De Novo Kidney Transplant Recipients
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmed_primary_27622692
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_27622692
Other Identifiers
ISSN
1420-4096
E-ISSN
1423-0143
DOI
10.1159/000447930
